15069545 | Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers. | Oncol Rep | 2004 May | Hotta T | - |
21111509 | Thymidylate synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer. | Lung Cancer | 2011 Jul | Takeda M | doi: 10.1016/j.lungcan.2010.10.022 |
16132996 | Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up. | Int J Colorectal Dis | 2006 Apr | Lassmann S | - |
18004243 | Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer. | Exp Oncol | 2007 Sep | Yu Z | - |
27127154 | Increase in Gene Expression of TYMP, DPYD and HIF1A Are Associated with Response to Preoperative Chemoradiotherapy Including S-1 or UFT for Rectal Cancer. | Anticancer Res | 2016 May | Sadahiro S | - |
19295264 | [Clinical significance of intratumoral TS levels and DPD activity in breast cancer]. | Gan To Kagaku Ryoho | 2009 Mar | Miyashita M | - |
19104657 | Strong association of a common dihydropyrimidine dehydrogenase gene polymorphism with fluoropyrimidine-related toxicity in cancer patients. | PLoS One | 2008 | Gross E | doi: 10.1371/journal.pone.0004003 |
17699798 | Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. | Cancer Res | 2007 Aug 15 | Krugluger W | - |
22143355 | Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma. | Surg Today | 2012 Jan | Morine Y | doi: 10.1007/s00595-011-0054-z |
19020767 | Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis. | Int J Mol Med | 2008 Dec | Fukui Y | - |
14519634 | Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. | Clin Cancer Res | 2003 Sep 15 | Kornmann M | - |
20837458 | Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer. | Clin Lung Cancer | 2010 Sep 1 | Grimminger PP | doi: 10.3816/CLC.2010.n.041. |
22641663 | Expression of dihydropyrimidine dehydrogenase, orotate phosphoribosyl transferase and thymidylate synthase in patients with primary colorectal cancer, and associations with site of first metastasis. | Anticancer Res | 2012 Jun | Akagi Y | - |
17417073 | Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity. | Ther Drug Monit | 2007 Apr | Cho HJ | - |
22006578 | TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy. | J Surg Oncol | 2012 May | Tanaka K | doi: 10.1002/jso.22123 |
27461651 | DPYD*2A/*5A/*9A and UGT1A1*6/*28 polymorphisms in Chinese colorectal cancer patients. | J Cancer Res Ther | 2016 Apr-Jun | Li GY | doi: 10.4103/0973-1482.148685. |
25112781 | Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer. | Gastric Cancer | 2015 Jul | Sasako M | doi: 10.1007/s10120-014-0413-8 |
14654904 | DPD activity and immunohistochemical DPD expression in human breast cancer. | Oncol Rep | 2004 Jan | Horiguchi J | - |
16786143 | The relationship between survival and the expression of dihydropyrimidine dehydrogenase in patients with colorectal cancer. | Oncol Rep | 2006 Jul | Hotta T | - |
25873402 | MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD. | IUBMB Life | 2015 Mar | Chai J | doi: 10.1002/iub.1361 |
20809970 | Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients. | BMC Cancer | 2010 Sep 1 | Savva-Bordalo J | doi: 10.1186/1471-2407-10-470. |
26372896 | Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study. | Oncotarget | 2015 Oct 20 | Baba H | doi: 10.18632/oncotarget.5227. |
17612628 | Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression. | Biochem Cell Biol | 2007 Jun | Zhang X | - |
16361556 | Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients. | Clin Cancer Res | 2005 Dec 15 | Ezzeldin HH | - |
20819423 | Variants in the dihydropyrimidine dehydrogenase, methylenetetrahydrofolate reductase and thymidylate synthase genes predict early toxicity of 5-fluorouracil in colorectal cancer patients. | J Int Med Res | 2010 May-Jun | Kristensen MH | - |
14562021 | Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. | Br J Cancer | 2003 Oct 20 | Ichikawa W | - |
20714877 | Relationship between the expression of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase and survival in epithelial ovarian cancer. | J Huazhong Univ Sci Technolog Med Sci | 2010 Aug | Wang C | doi: 10.1007/s11596-010-0456-y |
26281864 | Correlation between DPYD gene variation and KRAS wild type status in colorectal cancer. | J Clin Pathol | 2016 Mar | Kleist B | doi: 10.1136/jclinpath-2015-202903 |
15999119 | Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer. | Prostate Cancer Prostatic Dis | 2005 | Miyoshi Y | - |
22490566 | Polymorphisms of dihydropyrimidine dehydrogenase gene and clinical outcomes of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population. | Chin Med J (Engl) | 2012 Mar | Zhang XP | - |
21612699 | [Expression of dihydropyrimidine dehydrogenase negatively correlated with the prognosis of pancreatic ductal adenocarcinoma]. | Zhonghua Wai Ke Za Zhi | 2011 Apr 1 | Fang Y | - |
11992400 | Thymidine kinase in epithelial ovarian cancer: relationship with the other pyrimidine pathway enzymes. | Int J Cancer | 2002 May 20 | Fujiwaki R | - |
18619742 | The dihydrouracil/uracil ratio in plasma, clinical and genetic analysis for screening of dihydropyrimidine dehydrogenase deficiency in colorectal cancer patients treated with 5-fluorouracil. | Pathol Biol (Paris) | 2009 Sep | Ben Fredj R | doi: 10.1016/j.patbio.2008.05.001 |
17203168 | Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer. | Oncol Rep | 2007 Feb | Salgado J | - |
25066213 | Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. | Mol Nutr Food Res | 2014 Oct | Kelemen LE | doi: 10.1002/mnfr.201400068 |
16820886 | Deficient expression of the DPD gene is caused by epigenetic modification in biliary tract cancer cells, and induces high sensitivity to 5-FU treatment. | Int J Oncol | 2006 Aug | Sato K | - |
17582310 | [Pro or con the phenotyping/genotyping of patients treated by 5-Fluorouracil to prevent adverse drug reactions?]. | Therapie | 2007 Mar-Apr | Coriat R | - |
12576451 | Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. | Clin Cancer Res | 2003 Feb | Ichikawa W | - |
22593457 | Expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase in patients with colorectal cancer. | Anticancer Res | 2012 May | Goto T | - |
23401991 | [Review of methods for determination of dihydropyrimidine dehydrogenase and possible application in screening previous chemotheraphy with 5-fluorouracil]. | Przegl Lek | 2012 | Ostapowicz A | - |
18347391 | [Significance of pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogenase levels to predict postoperative recurrence in primary breast cancer]. | Gan To Kagaku Ryoho | 2008 Mar | Tamesa M | - |
19724871 | Microdissection is essential for gene expression analysis of irradiated rectal cancer tissues. | Oncol Rep | 2009 Oct | Inoue Y | - |
11895907 | Profound dihydropyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotype. | Clin Cancer Res | 2002 Mar | Johnson MR | - |
20647710 | [Correlation between clinicopathological factors and enzymatic activity of orotate phosphoribosyl transferase (OPRT), dihydropyrimidine dehydrogenase (DPD) in esophageal cancer]. | Gan To Kagaku Ryoho | 2010 Jul | Takemura M | - |
12851836 | Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutations in the DPD gene, and DPD inhibitory fluoropyrimidines. | Int J Clin Oncol | 2003 Jun | Omura K | - |
15993511 | The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells. | Lung Cancer | 2005 Sep | Oguri T | - |
28255193 | The Impact of the Expression Level of Intratumoral Dihydropyrimidine Dehydrogenase on Chemotherapy Sensitivity and Survival of Patients in Gastric Cancer: A Meta-Analysis. | Dis Markers | 2017 | Zhang C | doi: 10.1155/2017/9202676 |
19473056 | Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy. | Neoplasma | 2009 | Kleibl Z | - |
27741011 | Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study. | Ann Surg | 2016 Nov | Bollschweiler E | - |
27181275 | Evaluation of clinical implementation of prospective DPYD genotyping in 5-fluorouracil- or capecitabine-treated patients. | Pharmacogenomics | 2016 May | Lunenburg CA | doi: 10.2217/pgs-2016-0013 |
28476815 | Combined Analyses of hENT1, TS, and DPD Predict Outcomes of Borderline-resectable Pancreatic Cancer. | Anticancer Res | 2017 May | Yabushita Y | - |
27268079 | Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer. | BMC Cancer | 2016 Jun 6 | Tominaga T | doi: 10.1186/s12885-016-2392-0. |
29065426 | Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients. | Br J Cancer | 2017 Oct 24 | Ruzzo A | doi: 10.1038/bjc.2017.289 |
28929491 | Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiency. | Int J Cancer | 2018 Jan 15 | Henricks LM | doi: 10.1002/ijc.31065 |
29372689 | DPYD genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from Slovakia. | Gen Physiol Biophys | 2017 Dec | Matakova T | doi: 10.4149/gpb_2017046. |
28024938 | Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing. | Biochim Biophys Acta Mol Basis Dis | 2017 Mar | van Kuilenburg AB | doi: 10.1016/j.bbadis.2016.12.010 |
30114658 | Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapy. | Eur J Cancer | 2018 Oct | Madi A | doi: 10.1016/j.ejca.2018.07.009 |